Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The corona virus disease 2019 posed a major risk for end-stage kidney disease (ESKD) cases. Our study aimed to assess changes in kidney replacement therapy (KRT) trends and healthcare access for these patients during the pandemic. Methods: We retrospectively analyzed nationwide data from July 2017 to June 2022 to assess changes in KRT and ESKD incidence. KRT modalities included peritoneal dialysis (PD), hemodialysis (HD), and kidney transplantation (KT). We utilized the interrupted time series (ITS) method to compare changes in KRT modality before and after the incidence of the COVID-19 pandemic. Results: ESKD incidence remained stable from 2018 to April 2022. The ITS analysis confirmed that the pandemic did not significant impact overall KRT incidence. PD cases decreased (5.7% to 1.3%), while HD cases increased (81.6% to 85%), and KT recipient remained relatively stable (12.7% to 17.3%). The hospitalization and hospital stay decreased in nursing hospital (165.01 days to 147.77 days) and general hospital (61.34 days to 55.58 days) during the pandemic, however, remained unchanged for PD and KT. Conclusions: Our findings indicate no significant changes in ESKD incidence in South Korea during the pandemic. However, there were shifts in modality distribution, with decreased PD and increased HD cases. Notably, HD cases showed a significant reduction in hospital admissions and length of stay. The healthcare system demonstrated stability during the pandemic, with minimal disruptions in ESKD care.
Abstract
Background/Aims: The corona virus disease 2019 posed a major risk for end-stage kidney disease (ESKD) cases. Our study aimed to assess changes in kidney replacement therapy (KRT) trends and healthcare access for these patients during the pandemic. Methods: We retrospectively analyzed nationwide data from July 2017 to June 2022 to assess changes in KRT and ESKD incidence. KRT modalities included peritoneal dialysis (PD), hemodialysis (HD), and kidney transplantation (KT). We utilized the interrupted time series (ITS) method to compare changes in KRT modality before and after the incidence of the COVID-19 pandemic. Results: ESKD incidence remained stable from 2018 to April 2022. The ITS analysis confirmed that the pandemic did not significant impact overall KRT incidence. PD cases decreased (5.7% to 1.3%), while HD cases increased (81.6% to 85%), and KT recipient remained relatively stable (12.7% to 17.3%). The hospitalization and hospital stay decreased in nursing hospital (165.01 days to 147.77 days) and general hospital (61.34 days to 55.58 days) during the pandemic, however, remained unchanged for PD and KT. Conclusions: Our findings indicate no significant changes in ESKD incidence in South Korea during the pandemic. However, there were shifts in modality distribution, with decreased PD and increased HD cases. Notably, HD cases showed a significant reduction in hospital admissions and length of stay. The healthcare system demonstrated stability during the pandemic, with minimal disruptions in ESKD care.
참고문헌 (22)
- Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
- ERA-EDTA Council, "Chronic kidney disease is a key risk factor for severe COVID-19 : a call to action by the ERA-EDTA", Nephrol Dial Transplant, 36, pp.87~94 (2021)
- De Meester J, "Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy : a regionwide registry study", J Am Soc Nephrol, 32, pp.385~396 (2021)
- Changsirikulchai S, "COVID-19 incidence and outcomes among patients with kidney replacement therapy", Kidney Res Clin Pract, 42, pp.649~659 (2023)
- Park HC, "COVID-19-related clinical outcomes among Korean hemodialysis patients", Kidney Res Clin Pract, 41, pp.591~600 (2022)
- Chothia MY, "Impact of COVID-19on access to chronic kidney replacement therapy in the public sector of Western Cape Province, South Africa", S Afr Med J, 111, pp.13442~ (2021)
- Kyoung DS, "Understanding and utilizing claim data from the Korean National Health Insurance Service(NHIS)and Health Insurance Review & Assessment(HIRA)database for research", J Lipid Atheroscler, 11, pp.103~110 (2022)
- "Population Projections for Korea: population trends and projections of the world and Korea" (2023)[URL]
- Lee MJ, "Trends in the incidence, prevalence, and mortality of end-stage kidney disease in South Korea", Diabetes Metab J, 44, pp.933~937 (2020)
- Obi Y, "Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA", Nephrol Dial Transplant, 32(suppl_2), pp.ii99~ii105 (2017)
- Wagner AK, "Segmented regression analysis of interrupted time series studies in medication use research", J Clin Pharm Ther, 27, pp.299~309 (2002)
- National Health Insurance Service, Health Insurance Review & Assessment Service, "2021 medical aid statistics", Health Insurance Review & Assessment Service, ~ (2022)
- Quan H, "Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data", Med Care, 43, pp.1130~1139 (2005)
- Hirsch JS, "Acute kidney injury in patients hospitalized with COVID-19", Kidney Int, 98, pp.209~218 (2020)
- Weinhandl ED, "COVID-19-associated decline in the size of the end-stage kidney disease population in the United States", Kidney Int Rep, 6, pp.2698~2701 (2021)
- Hong YA, "Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System(KORDS)", Kidney Res Clin Pract, 40, pp.52~61 (2021)
- Tonelli M, "Systematic review : kidney transplantation compared with dialysis in clinically relevant outcomes", Am J Transplant, 11, pp.2093~2109 (2011)
- Huang QS, "Impact of the COVID-19nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand", Nat Commun, 12, pp.1001~ (2021)
- Toyama T, "Age differences in the relationships between risk factors and loss of kidney function : a general population cohort study", BMC Nephrol, 21, pp.477~ (2020)
- Harambat J, "Epidemiology of chronic kidney disease in children", Pediatr Nephrol, 27, pp.363~373 (2012)
- McCullough KP, "Projecting ESRD incidence and prevalence in the United States through 2030", J Am Soc Nephrol, 30, pp.127~135 (2019)
- "In-depth analysis of changes in mortality since the outbreak of COVID-19" (2023)[URL]